Gimv: A Belgian private equity firm investing in select platforms across Benelux, France, and Germany.
Location
Antwerp, BE
Founded
1980
Gimv is a Belgian private equity firm that focuses on investing in select platforms across the Benelux region, France, and Germany. The firm targets various sectors, including Consumer, Healthcare, Life Sciences, Smart Industries, and Sustainable Cities. Gimv typically participates in investment rounds ranging from Seed to Series D, as well as private equity rounds.
Notable portfolio companies include AGY Therapeutics, Ambit Biosciences, EndoStim, Inside Secure, Kinaset Therapeutics, Mediar Therapeutics, Micron Technology, Ubidyne, and Well Services Group. Gimv's investment philosophy centers on building leading companies within its focused sectors. The firm offers unique value-add services to its portfolio companies, leveraging its extensive industry expertise and regional presence to drive growth and innovation.
Gimv - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages